NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

Nobody here has forgotten Direct, and everybody knows its unrealised potential.
But there have been several false starts on Direct P2's in the last few years, due to them not having the necessary wherewithall.
And that is definitely still the case. Everything has to be committed to concluding the L trial.

Unless a fairy godmother comes along.

(And if one does, imo that won't be Merck, as Merck will do nothing to advance the development of a drug that would potentially put at risk their revenue from a certain other top-selling drug. JMO.)